Advocating for a world where intellectual
property law serves the public interest.
[Ernesto, TorrentFreak, Link (CC-BY-NC)] A Greek anti-piracy group has lost its bid to have various torrent sites blocked by local Internet providers. The Athens Court ruled that barring access to torrent sites such as KickassTorrents and The Pirate Bay is disproportionate and unconstitutional, while hindering the ISPs’ entrepreneurial freedoms. Author REPOST
As you might know, the Centre for Internet and Society, India will be hosting the 4th Global Congress on Intellectual Property and the Public Interest at New Delhi, India. We’re pleased to welcome on board National Law University, New Delhi (“NLU-D”), as our Institutional Partner. NLU-D will be the venue for the Congress, later this […]
Will 2015 be the year of European copyright reform? [Theresa Hackett, EIFL, Link (CC-BY)] “Copyright divide in numbers”, the graph on the first page of the newly launched ‘The Copyright Manifesto. How the European Union should Support Innovation and Creativity through Copyright Reform’ tells a story. In an illustration of the results of the European […]
[Rishika for the Centre for Internet and Society, Link (CC-BY)] In the year 2006, the World Intellectual Property Organization (WIPO) conducted a study on different national approaches to copyright exception for persons with disabilities. Over 60 countries have an exception in their Copyright laws permitting conversion of works into accessible formats for the benefit of […]
[Federal Register Notice from the office of the U.S. Trade Representative, Link] …USTR is hereby requesting written submissions from the public concerning foreign countries that deny adequate and effective protection of intellectual property rights or deny fair and equitable market access to U.S. persons who rely on intellectual property protection… Dates/Deadlines: The schedule and deadlines […]
[[Médecins Sans Frontières, Link] The Indian Patent Controller has today rejected one of Gilead’s key patent applications which covered the drug sofosbuvir, used to treat hepatitis C (HCV). The oral drug, which first received regulatory approval in the US in November 2013, and has been priced by Gilead at US$84,000 for a treatment course, or […]
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources